Galapagos NV

Galapagos Creates New Subscription Right Plan

07 8月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

05 8月 2025 22:30:00 条件 Nasdaq GlobeNewswire

Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Transformation

23 7月 2025 13:03:00 条件 Nasdaq GlobeNewswire

Galapagos Welcomes Seasoned Pharmaceutical Executives Dawn Svoronos and Jane Griffiths to Its Board of Directors

23 7月 2025 13:02:00 条件 Nasdaq GlobeNewswire

Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business Update

23 7月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Galapagos Appoints Aaron Cox as Chief Financial Officer

22 6月 2025 22:30:00 条件 Nasdaq GlobeNewswire

Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101

18 6月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL

12 6月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Galapagos Creates New Subscription Right Plan

27 5月 2025 13:33:01 条件 Nasdaq GlobeNewswire

Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101

14 5月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Galapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes

12 5月 2025 22:35:54 条件 Nasdaq GlobeNewswire

Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts

23 4月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Galapagos Announces Executive Leadership Updates

21 4月 2025 13:10:00 条件 Nasdaq GlobeNewswire

Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025

14 4月 2025 22:30:00 条件 Nasdaq GlobeNewswire

Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders’ Meeting

27 3月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Galapagos to Present at Upcoming Investor Conferences

24 2月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Galapagos receives transparency notification and 13D filing from Tang Capital

17 2月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update

12 2月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

07 1月 2025 22:30:00 条件 Nasdaq GlobeNewswire

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

07 1月 2025 13:01:00 条件 Nasdaq GlobeNewswire